PPARA and eosinophilia-myalgia syndrome: Our study indicates that resveratrol functions as an agonist to stimulate PPARα activation and may also interplay more directly with the lipid-associated pathways that contribute to the improvement in the prognosis of EMs (Supplementary Figure 4).